DE69122605D1 - 2-nitroimidazolderivat, verfahren zu dessen herstellung und dieses als aktiven bestandteil enthaltender strahlungssensibilisator - Google Patents

2-nitroimidazolderivat, verfahren zu dessen herstellung und dieses als aktiven bestandteil enthaltender strahlungssensibilisator

Info

Publication number
DE69122605D1
DE69122605D1 DE69122605T DE69122605T DE69122605D1 DE 69122605 D1 DE69122605 D1 DE 69122605D1 DE 69122605 T DE69122605 T DE 69122605T DE 69122605 T DE69122605 T DE 69122605T DE 69122605 D1 DE69122605 D1 DE 69122605D1
Authority
DE
Germany
Prior art keywords
production
active component
nitroimidazole derivative
radiation sensitizer
sensitizer containing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69122605T
Other languages
English (en)
Other versions
DE69122605T2 (de
Inventor
Toshimitsu Suzuki
Masakazu Sakaguchi
Yoshiyuki Miyata
Akira Suzuki
Tomoyuki Mori
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pola Chemical Industries Inc
Original Assignee
Pola Chemical Industries Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pola Chemical Industries Inc filed Critical Pola Chemical Industries Inc
Publication of DE69122605D1 publication Critical patent/DE69122605D1/de
Application granted granted Critical
Publication of DE69122605T2 publication Critical patent/DE69122605T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/91—Nitro radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DE69122605T 1990-01-26 1991-01-24 2-nitroimidazolderivat, verfahren zu dessen herstellung und dieses als aktiven bestandteil enthaltender strahlungssensibilisator Expired - Lifetime DE69122605T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2016721A JP2626727B2 (ja) 1990-01-26 1990-01-26 ２―ニトロイミダゾール誘導体、その製造法及びこれを有効成分とする放射線増感剤
PCT/JP1991/000074 WO1991011440A1 (fr) 1990-01-26 1991-01-24 Derive de 2-nitroimidazole, sa fabrication, et agent radiosensibilisant le renfermant comme principe actif

Publications (2)

Publication Number Publication Date
DE69122605D1 true DE69122605D1 (de) 1996-11-14
DE69122605T2 DE69122605T2 (de) 1997-02-13

Family

ID=11924130

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69122605T Expired - Lifetime DE69122605T2 (de) 1990-01-26 1991-01-24 2-nitroimidazolderivat, verfahren zu dessen herstellung und dieses als aktiven bestandteil enthaltender strahlungssensibilisator

Country Status (10)

Country Link
US (1) US5270330A (de)
EP (1) EP0513351B1 (de)
JP (1) JP2626727B2 (de)
KR (2) KR927003539A (de)
AT (1) ATE143950T1 (de)
CA (1) CA2074533C (de)
DE (1) DE69122605T2 (de)
DK (1) DK0513351T3 (de)
ES (1) ES2094218T3 (de)
WO (1) WO1991011440A1 (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0632028T3 (da) * 1992-12-18 2003-07-21 Pola Chem Ind Inc Optisk aktivt 2-nitroimidazolderivat, fremgangsmåde til fremstilling af samme og mellemprodukt til fremstilling af samme
US6060604A (en) * 1995-03-31 2000-05-09 Florida State University Pharmaceutical compounds comprising polyamines substituted with electron-affinic groups
US5700825A (en) * 1995-03-31 1997-12-23 Florida State University Radiosensitizing diamines and their pharmaceutical preparations
US6331286B1 (en) 1998-12-21 2001-12-18 Photogen, Inc. Methods for high energy phototherapeutics
US5929104A (en) * 1997-04-02 1999-07-27 Pola Chemical Industries, Inc. Method for inducing apoptosis of cancer cell
US8974363B2 (en) 1997-12-11 2015-03-10 Provectus Pharmatech, Inc. Topical medicaments and methods for photodynamic treatment of disease
US8557298B2 (en) 1998-08-06 2013-10-15 Provectus Pharmatech, Inc. Medicaments for chemotherapeutic treatment of disease
US7384623B1 (en) 1998-12-21 2008-06-10 Provectus Pharmatech, Inc. High energy phototherapeutic agents
US8470296B2 (en) * 1998-12-21 2013-06-25 Provectus Pharmatech, Inc. Intracorporeal medicaments for high energy phototherapeutic treatment of disease
US20020001567A1 (en) * 1998-12-21 2002-01-03 Photogen, Inc. Intracorporeal medicaments for high energy phototherapeutic treatment of disease
EP1594459B1 (de) 2002-12-30 2010-02-17 Angiotech International Ag Wirkstofffreisetzung von schnell gelierender polymerzusammensetzung
JP2006522021A (ja) * 2003-02-03 2006-09-28 パロ アルト インスティチュート オブ モレキュラー メディシン 殺細胞分子およびその使用方法
ZA200507752B (en) 2003-03-28 2007-01-31 Threshold Pharmaceuticals Inc Compositions and methods for treating cancer
US20080132458A1 (en) * 2004-03-10 2008-06-05 Threshold Pharmaceuticals, Inc. Hypoxia-Activated Anti-Cancer Agents
EP1734046B1 (de) * 2004-06-24 2010-09-01 Toyo Suisan Kaisha, Ltd. Sulfopyranosylacylglycerol-Derivate zur Anwendung in Kombination mit Bestrahlung in einer Tumor-Radiotherapie
US7608612B2 (en) * 2005-01-21 2009-10-27 Richard H. Matthews Radiosensitizer formulations and methods for use
PL1896040T3 (pl) 2005-06-29 2012-12-31 Threshold Pharmaceuticals Inc Proleki alkilatora fosforoamidowego
WO2008083101A1 (en) * 2006-12-26 2008-07-10 Threshold Pharmaceuticals, Inc. Phosphoramidate alkylator prodrugs for the treatment of cancer
EP2128140B1 (de) 2007-01-23 2012-03-14 Pola Pharma Inc. Verfahren zur herstellung eines 2-nitroimidazol-derivats
JP5297815B2 (ja) * 2007-01-26 2013-09-25 株式会社ポーラファルマ 医薬組成物
US8258165B2 (en) 2007-06-14 2012-09-04 Pola Pharma Inc. Pharmaceutical composition
US20090118031A1 (en) * 2007-11-01 2009-05-07 Qualizza Gregory K Shaft Structure with Configurable Bending Profile
JP6071715B2 (ja) * 2013-03-22 2017-02-01 株式会社ポーラファルマ ドラニダゾール構成光学異性体の製造方法
JP6082644B2 (ja) * 2013-03-22 2017-02-15 株式会社ポーラファルマ ドラニダゾール構成光学異性体の製造方法
EP3692990A4 (de) 2017-10-02 2021-06-30 Keio University Krebsstammzellinhibitor

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4462992A (en) * 1982-02-08 1984-07-31 Research Corporation Nitroimidazole radiosensitizers for hypoxic tumor cells and compositions thereof
JPS59139363A (ja) * 1983-01-31 1984-08-10 Kayaku:Kk ２−ニトロイミダゾ−ル誘導体およびその製造法
JPS6075430A (ja) * 1983-08-31 1985-04-27 Kayaku:Kk 放射線増感剤
JPH0819111B2 (ja) * 1987-10-22 1996-02-28 ポーラ化成工業株式会社 ２―ニトロイミダゾール誘導体及びこれを有効成分とする放射線増感剤
JP3291590B2 (ja) * 1992-08-26 2002-06-10 キヤノン株式会社 カラートナー、カラー現像剤及び画像形成方法

Also Published As

Publication number Publication date
KR0145333B1 (en) 1998-07-15
DK0513351T3 (da) 1996-11-25
US5270330A (en) 1993-12-14
JP2626727B2 (ja) 1997-07-02
JPH03223258A (ja) 1991-10-02
KR927003539A (ko) 1992-12-18
EP0513351B1 (de) 1996-10-09
EP0513351A1 (de) 1992-11-19
WO1991011440A1 (fr) 1991-08-08
ES2094218T3 (es) 1997-01-16
EP0513351A4 (en) 1993-11-10
ATE143950T1 (de) 1996-10-15
CA2074533A1 (en) 1991-07-27
DE69122605T2 (de) 1997-02-13
CA2074533C (en) 2000-10-17

Similar Documents

Publication Publication Date Title
DE69122605D1 (de) 2-nitroimidazolderivat, verfahren zu dessen herstellung und dieses als aktiven bestandteil enthaltender strahlungssensibilisator
ATE153025T1 (de) Triazolopyrimidinderivate mit fungizider aktivität
HU9300110D0 (en) Method for producing aryl-cycloalkyl derivatives and medical preparatives containing them as active substance
ATE101601T1 (de) Fluorhaltige nitrazol-derivate und diese umfassender strahlungssensibilisator.
MY103241A (en) Imidazole and 1,2,4 triazole derivatives
ATE205199T1 (de) Quinolin- oder quinazolinderivate, deren herstellung und verwendung
NO951283L (no) Nye taxanderivater, deres fremstilling samt farmasöytiske preparater inneholdende derivatene
ATE211474T1 (de) Galanthamin derivate, verfahren zu ihrer herstellung und ihre verwendung als medikamente
ES2073258T3 (es) Nuevos derivados de la urea, su preparacion y su aplicacion en terapeutica.
FI935243A0 (fi) Pyridonkarboxylsyraderivat
GB9715895D0 (en) Heterocyclic compounds
NO961236L (no) Pyrrolodiazin-derivater som stabilisatorer for klorholdige polymerisater
ATE78163T1 (de) Stickstoff enthaltende heterozyklische verbindungen.
ES8303393A1 (es) Un procedimiento para preparar derivados del acido ascorbico.
ATE42295T1 (de) Penem-derivate, verfahren zu deren herstellung, ihre verwendung und pharmazeutische zusammensetzungen.
GR3015209T3 (en) Imidazole derivatives, process for their fabrication and pharmaceutical compositions containing them.
ES2061556T3 (es) Derivados amida y su produccion y fungicidas agricolas que los contienen.
ES8501607A1 (es) Procedimiento para la obtencion de heterociclos nitrogenosos de 5 miembros
ATE20588T1 (de) Heterozyklische verbindungen geeignet als pestizide und verfahren zu ihrer herstellung.
DE69031730T2 (de) Neues Antibiotikum, Deoxymulündocandin, Verfahren zu seiner Produktion und Verwendung als Medikament
ITMI920082A1 (it) Derivati solforati di acidi biliari
NO932002L (no) Nye tiosemikarbazonsyreestere
ATE26575T1 (de) Substituierte 9h-8-oxo-pyrimido(2,1-f)purin-2,4- dione, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen.
HUT50132A (en) Process for producing 2-cyano-2-phenyl-1-/azol-1-yl/-ethan derivatives, and fungicide compositions containing them as active components
IT1254471B (it) Derivati ammidici della (r)-glicerofosforil-(s)-serina o del suo diacil derivato, un processo per la loro preparazione e relative composizioni farmaceutiche per il potenziamento dei processi di apprendimento

Legal Events

Date Code Title Description
8364 No opposition during term of opposition